Harold Brakewood
Fortuna: 55 140 $ al 30/06/2026
Fortuna: 55 140 $ al 30/06/2026
Harold E.
Brakewood is Chief Business Officer at Immuneering Corp.
since 2023.
From 2015 to 2021, served as Vice President & Head-Oncology Business Unit at Regeneron Pharmaceuticals, Inc. Education includes undergraduate degree from Bowdoin College, graduate degree from Dartmouth College, and MBA from Harvard Business School.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 03/02/2026 | 11.050 ( 0,02 % ) | 55 140 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| IMMUNEERING CORPORATION | Corporate Officer/Principal | 28/03/2023 |
| Empresas | Cargo | Fin |
|---|---|---|
| REGENERON PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/12/2021 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and commercializes medicines for diseases | Health Technology |
Dartmouth College
Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bowdoin College
Bowdoin College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immuneering Corp.
Immuneering Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, focuses on the oncology and neuroscience product candidates | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.